Adenosine Monophosphate

cyclin dependent kinase inhibitor 2A ; Homo sapiens







27 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
1 31001908 A novel CDKN2A variant (p16L117P ) in a patient with familial and multiple primary melanomas. 2019 Sep 2
2 31270053 [Correlation between methylation level of CDKN2A and CDKN2B genes and aging in healthy individuals]. 2019 Jun 30 1
3 29162510 Unravelling the link between embryogenesis and cancer metastasis. 2018 Feb 5 1
4 29697437 Routine Use of Adjunctive p16 Immunohistochemistry Improves Diagnostic Agreement of Cervical Biopsy Interpretation: Results From the CERTAIN Study. 2018 Aug 1
5 29966311 Dynamics of p14ARF and Focal Adhesion Kinase-Mediated Autophagy in Cancer. 2018 Jun 29 2
6 30305801 Prognostic significance of p16 & p53 immunohistochemical expression in triple negative breast cancer. 2018 1
7 27209505 Effect of p16 Status on the Quality-of-Life Experience During Chemoradiation for Locally Advanced Oropharyngeal Cancer: A Substudy of Randomized Trial Trans-Tasman Radiation Oncology Group (TROG) 02.02 (HeadSTART). 2017 Mar 15 1
8 28916224 Lack of differences in radiation-induced immunogenicity parameters between HPV-positive and HPV-negative human HNSCC cell lines. 2017 Sep 1
9 28932295 Expression of MDM2 mRNA, MDM2, P53 and P16 Proteins in Urothelial Lesions in the View of the WHO 4th Edition Guidelines as a Molecular Insight towards Personalized Medicine. 2017 Aug 15 1
10 27040135 E1 detection as prognosticator in human papillomavirus-positive head and neck cancers. 2016 Apr-Jun 1
11 27837640 Micro-RNAs in p16INK4A (CDKN2A gene) deregulation: A novel molecular approach in cervical and head & neck carcinomas. 2016 Sept-Oct 2
12 26125737 Immunohistochemical detection and clinicopathological significance of JARID1B/KDM5B and P16 expression in invasive ductal carcinoma of the breast. 2015 May 22 1
13 25389329 p16INK4a immunohistochemistry in cervical biopsy specimens: A systematic review and meta-analysis of the interobserver agreement. 2014 Dec 2
14 24350944 Prognostic utility of basaloid differentiation in oropharyngeal cancer. 2013 Dec 19 2
15 22440936 p16 gene mutations in Barrett's esophagus in gastric metaplasia - intestinal metaplasia - dysplasia - adenocarcinoma sequence. 2012 Jun 1 1
16 16831267 [Construction and study of replication-defective adenovirus targeting hepatocarcinoma]. 2006 Jul 1
17 15837618 Snf5 tumor suppressor couples chromatin remodeling, checkpoint control, and chromosomal stability. 2005 Apr 1
18 16028838 p16(INK4a) as a complementary marker of high-grade intraepithelial lesions of the uterine cervix. I: Experience with squamous lesions in 189 consecutive cervical biopsies. 2005 Apr 2
19 15191661 [Synergism of c-myc and p16 in oral squamous cell carcinoma]. 2004 Jun 1
20 12561435 [Influence of p16 gene on the biological behavior of human hepatocellular carcinoma]. 2003 Jan 1
21 12600300 [Preliminary study of p16 gene expression in pituitary adenomas]. 2003 Feb 1
22 11910361 p16 inactivation by methylation of the CDKN2A promoter occurs early during neoplastic progression in Barrett's esophagus. 2002 Apr 1
23 12105864 Aberrant methylation of CpG islands in intraductal papillary mucinous neoplasms of the pancreas. 2002 Jul 1
24 11040180 p16(INK4a) expression begins early in human colon neoplasia and correlates inversely with markers of cell proliferation. 2000 Oct 3
25 9922321 p16(INK4) is inactivated by extensive CpG methylation in human hepatocellular carcinoma. 1999 Feb 2
26 9834265 Hypermethylation of the CDKN2/p16 promoter during neoplastic progression in Barrett's esophagus. 1998 Dec 3
27 8613012 Frequent codeletion of p16/MTS1 and p15/MTS2 and genetic alterations in p16/MTS1 in pancreatic tumors. 1996 Apr 2